Showing results (1201-1210 of 1,294) with videos related to
Sort By:
Pageof 130
Paediatric Drugs|November 11, 2020
Optimizing the Use of Antibiotic Agents in the Pediatric Intensive Care Unit: A Narrative ReviewJef Willems, Eline Hermans, Petra Schelstraete, et al.Paediatric Drugs|September 5, 2020
Treatment of Juvenile Spondyloarthritis: Where We StandJohn M Bridges, Matthew L StollPaediatric Drugs|September 5, 2020
Adherence to Medication During Transition to Adult ServicesBianca R Campagna, Kristen Weatherley, Eyal Shemesh, et al.Paediatric Drugs|November 24, 2020
Drug Use in Pediatric Patients Admitted to Rehabilitation For Severe Acquired Brain Injury: Analysis of the Associations With Rehabilitation OutcomesMarco Pozzi, Sara Galbiati, Federica Locatelli, et al.Paediatric Drugs|January 23, 2020
New Developments in the Treatment of X-Linked Hypophosphataemia: Implications for Clinical ManagementVrinda Saraff, Ruchi Nadar, Wolfgang HöglerPaediatric Drugs|December 15, 2018
Clinical Features and Treatment of Down Syndrome Arthropathy: Experience from Two US Tertiary HospitalsJordan T Jones, Nasreen Talib, Daniel Lovell, et al.Paediatric Drugs|August 16, 2017
Advances in Vaccines to Prevent Viral Respiratory Illnesses in ChildrenAleisha J Anderson, Tom L Snelling, Hannah C Moore, et al.Paediatric Drugs|August 16, 2017
Tiotropium Bromide in Children and Adolescents with AsthmaHengameh H Raissy, H William KellyPaediatric Drugs|March 24, 2018
Optimizing Amikacin Dosage in Pediatrics Based on Population Pharmacokinetic/Pharmacodynamic ModelingSaeed Alqahtani, Manal Abouelkheir, Abdullah Alsultan, et al.Paediatric Drugs|October 29, 2017
Anti-Tumour Necrosis Factor Therapy for Paediatric Crohn's Disease: Improved Benefits Through Treatment Optimisation, Deeper Understanding of Its Risks, and Reduced Costs due to Biosimilar AvailabilityM A Cozijnsen, J N Samsom, L de RidderPageof 130